General Information
Revision date
2019-07-01
Product name
Canertinib, Dihydrochloride Salt
CAS No.
289499-45-2
Icons in SDS
Company Information
company name
LC Laboratories
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H302+H312+H332
Hazard statements
Code
Statements
H302+H312+H332
Harmful if swallowed, in contact with skin or if inhaled
Section 2
Hazard statements
Irritant Irritating to the skin and eyes May be harmful if inhaled, swallowed, or through skin absorption Exposure may result in cutaneous toxicity (erythematous macular-papular rash), diarrhea, nausea, vomiting, asthenia (general weakness and drowsiness), mucositis/stomatitis (inflammation/ulceration of the mucous membranes lining of the mouth and digestive tract), thrombocytopenia (low platelet count), dyspnea (shortness of breath), anemia, keratitis sicca (dry eye with inflammation of the conjuctiva and cornea), blood and liver chemistry changes May cause irritation of the respiratory tract H302+312+332 - Harmful if swallowed, in contact with skin or if inhaled
Signal word
Danger
Precautionary statements
P2562 - Do not get in eyes, on skin or on clothing WARNING For Laboratory Research Use Only
